Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2011 Apr 29;2(4):266–272. doi: 10.1007/s13238-011-1041-2

Contribution of cancer stem cells to tumor vasculogenic mimicry

Xiao-hong Yao 1, Yi-fang Ping 1, Xiu-wu Bian 1,✉
PMCID: PMC4875209  PMID: 21533771

Abstract

Vasculogenic mimicry (VM), a newly-defined pattern of tumor blood supply, provides a special passage without endothelial cells and is conspicuously different from angiogenesis and vasculogenesis. The biological features of the tumor cells that form VM remain unknown. Cancer stem cells (CSCs) are believed to be tumor-initiating cells, capable of self-renewal and multipotent differentiation, which resemble normal stem cells in phenotype and function. Recently CSCs have been shown to contribute to VM formation as well as angiogenesis. These findings challenge the previous understanding of the cellular basis of VM formation. In this review, we present evidence for participation of CSCs in VM formation. We also discuss the potential mechanisms and possible interaction of CSCs with various elements in tumor microenvironment niche. Based on the importance of VM in tumor progression, it constitutes a novel therapeutic target for cancer.

Keywords: cancer stem cell, vasculogenic mimicry, differentiation plasticity, niche, microenvironment

References

  1. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A. B., Shi Q., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006;66:7843–7848. doi: 10.1158/0008-5472.CAN-06-1010. [DOI] [PubMed] [Google Scholar]
  2. Basu G.D., Liang W.S., Stephan D.A., Wegener L.T., Conley C.R., Pockaj B.A., Mukherjee P. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res. 2006;8:R69. doi: 10.1186/bcr1626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., Terzis A. J.A. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer. 2005;5:899–904. doi: 10.1038/nrc1740. [DOI] [PubMed] [Google Scholar]
  4. Bussolati B., Grange C., Sapino A., Camussi G. Endothelial cell differentiation of human breast tumour stem/ progenitor cells. J Cell Mol Med. 2009;13:309–319. doi: 10.1111/j.1582-4934.2008.00338.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11:69–82. doi: 10.1016/j.ccr.2006.11.020. [DOI] [PubMed] [Google Scholar]
  6. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395. doi: 10.1038/74651. [DOI] [PubMed] [Google Scholar]
  7. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells-perspectives on current status and future direction: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344. doi: 10.1158/0008-5472.CAN-06-3126. [DOI] [PubMed] [Google Scholar]
  8. D’Amour K.A., Gage F.H. Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. Proc Natl Acad Sci U S A. 2003;100:11866–11872. doi: 10.1073/pnas.1834200100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dorsam R.T., Gutkind J.S. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7:79–94. doi: 10.1038/nrc2069. [DOI] [PubMed] [Google Scholar]
  10. Eccles S.A., Welch D.R. Metastasis: recent discoveries and novel treatment strategies. Lancet. 2007;369:1742–1757. doi: 10.1016/S0140-6736(07)60781-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elias A.P., Dias S. Microenvironment changes (in pH) affect VEGF alternative splicing. Cancer Microenviron. 2008;1:131–139. doi: 10.1007/s12307-008-0013-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Elzarrad K., Haroon A., Reed D., Al-Mehdi A.B. Early incorporated endothelial cells as origin of metastatic tumor vasculogenesis. Clin Exp Metastasis. 2009;26:589–598. doi: 10.1007/s10585-009-9257-8. [DOI] [PubMed] [Google Scholar]
  13. Folberg R., Hendrix M.J., Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000;156:361–381. doi: 10.1016/S0002-9440(10)64739-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Folberg R., Maniotis A.J. Vasculogenic mimicry. APMIS. 2004;112:508–525. doi: 10.1111/j.1600-0463.2004.apm11207-0810.x. [DOI] [PubMed] [Google Scholar]
  15. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273–286. doi: 10.1038/nrd2115. [DOI] [PubMed] [Google Scholar]
  16. Frenkel S., Barzel I., Levy J., Lin A.Y., Bartsch D.U., Majumdar D., Folberg R., Pe’er J. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye (Lond) 2008;22:948–952. doi: 10.1038/sj.eye.6702783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fujimoto A.O.H., Onodera H., Mori A., Nagayama S., Yonenaga Y., Tachibana T. Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells. Anticancer Res. 2006;26:59–69. doi: 10.1586/14737140.6.1.59. [DOI] [PubMed] [Google Scholar]
  18. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64:7011–7021. doi: 10.1158/0008-5472.CAN-04-1364. [DOI] [PubMed] [Google Scholar]
  19. Gao J.X. Cancer stem cells: the lessons from precancerous stem cells. J Cell Mol Med. 2007;58:267–284. [Google Scholar]
  20. Hendrix M.J., Seftor E.A., Hess A.R., Seftor R.E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003;3:411–421. doi: 10.1038/nrc1092. [DOI] [PubMed] [Google Scholar]
  21. Hendrix M.J., Seftor E.A., Kirschmann D.A., Quaranta V., Seftor R.E. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci. 2003;995:151–161. doi: 10.1111/j.1749-6632.2003.tb03218.x. [DOI] [PubMed] [Google Scholar]
  22. Hendrix M.J., Seftor E.A., Meltzer P.S., Gardner L.M., Hess A.R., Kirschmann D.A., Schatteman G.C., Seftor R.E. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A. 2001;98:8018–8023. doi: 10.1073/pnas.131209798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hess A.R., Seftor E.A., Seftor R.E., Hendrix M.J. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 2003;63:4757–4762. [PubMed] [Google Scholar]
  24. Hillen F., Griffioen A.W. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007;26:489–502. doi: 10.1007/s10555-007-9094-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–715. doi: 10.1016/j.cell.2008.03.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M.G., Pe’er J., Trent J.M., Meltzer P.S., Hendrix M.J.C. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155:739–752. doi: 10.1016/S0002-9440(10)65173-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Morel A.P., Lièvre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008;3:e2888. doi: 10.1371/journal.pone.0002888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Morrison S.J., Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006;441:1068–1074. doi: 10.1038/nature04956. [DOI] [PubMed] [Google Scholar]
  29. Na D.C., Lee J.E., Yoo J.E., Oh B.K., Choi G.H., Park Y.N. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol. 2011;90:66–73. doi: 10.1016/j.yexmp.2010.10.003. [DOI] [PubMed] [Google Scholar]
  30. Nakano I., Saigusa K., Kornblum H.I. BMPing off glioma stem cells. Cancer Cell. 2008;13:3–4. doi: 10.1016/j.ccr.2007.12.018. [DOI] [PubMed] [Google Scholar]
  31. Pezzolo A., Parodi F., Corrias M.V., Cinti R., Gambini C., Pistoia V. Tumor origin of endothelial cells in human neuroblastoma. J Clin Oncol. 2007;25:376–383. doi: 10.1200/JCO.2006.09.0696. [DOI] [PubMed] [Google Scholar]
  32. Piccirillo S.G., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Broggi G., Brem H., Olivi A., Dimeco F., Vescovi A.L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444:761–765. doi: 10.1038/nature05349. [DOI] [PubMed] [Google Scholar]
  33. Ping Y.F., Bian X.W. Cancer stem cells switch on tumor neovascularization. Curr Mol Med. 2011;11:69–75. doi: 10.2174/156652411794474383. [DOI] [PubMed] [Google Scholar]
  34. Ping Y.F., Yao X.H., Bian X.W., Chen J.H., Zhang R., Yi L., Zhou Z.H. Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis. Zhonghua Bing Li Xue Za Zhi. 2007;36:179–183. [PubMed] [Google Scholar]
  35. Ping, Y.F., Yao, X.H., Jiang, J.Y., Zhao, L.T., Yu, S.C., Jiang, T., Lin, M. C., Chen, J.H., Wang, B., Zhang, R., Cui, Y.H., Qian, C., Wang, J. M., and Bian, X.W. (2011). The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumor angiogenesis via PI3K/AKT signaling. J Pathol doi: 10.1002/path.2908 [DOI] [PubMed]
  36. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003;423:409–414. doi: 10.1038/nature01593. [DOI] [PubMed] [Google Scholar]
  37. Rigolin G.M., Fraulini C., Ciccone M., Mauro E., Bugli A.M., De Angeli C., Negrini M., Cuneo A., Castoldi G. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood. 2006;107:2531–2535. doi: 10.1182/blood-2005-04-1768. [DOI] [PubMed] [Google Scholar]
  38. Rothhammer T., Bataille F., Spruss T., Eissner G., Bosserhoff A.K. Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene. 2007;26:4158–4170. doi: 10.1038/sj.onc.1210182. [DOI] [PubMed] [Google Scholar]
  39. Scadden D.T. The stem-cell niche as an entity of action. Nature. 2006;441:1075–1079. doi: 10.1038/nature04957. [DOI] [PubMed] [Google Scholar]
  40. Schatton T., Frank M.H. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 2008;21:39–55. doi: 10.1111/j.1755-148X.2007.00427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., et al. Identification of cells initiating human melanomas. Nature. 2008;451:345–349. doi: 10.1038/nature06489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schofield R. The relationship between the spleen colonyforming cell and the haemopoietic stem cell. Blood Cells. 1978;4:7–25. [PubMed] [Google Scholar]
  43. Shen R., Ye Y., Chen L., Yan Q.T., Barsky S.H., Gao J.X. Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE. 2008;3:e1652. doi: 10.1371/journal.pone.0001652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Shirakawa K., Wakasugi H., Heike Y., Watanabe I., Yamada S., Saito K., Konishi F. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer. 2002;99:821–828. doi: 10.1002/ijc.10423. [DOI] [PubMed] [Google Scholar]
  45. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401. doi: 10.1038/nature03128. [DOI] [PubMed] [Google Scholar]
  46. Stevens A.P., Spangler B., Wallner S., Kreutz M., Dettmer K., Oefner P.J., Bosserhoff A.K. Direct and tumor microenvironment mediated influences of 5′-deoxy-5′-(methylthio) adenosine on tumor progression of malignant melanoma. J Cell Biochem. 2009;106:210–219. doi: 10.1002/jcb.21984. [DOI] [PubMed] [Google Scholar]
  47. Su M., Feng Y.J., Yao L.Q., Cheng M.J., Xu C.J., Huang Y., Zhao Y.Q., Jiang H., Su M., Feng Y.J., et al. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer. 2008;18:476–486. doi: 10.1111/j.1525-1438.2007.01034.x. [DOI] [PubMed] [Google Scholar]
  48. Sun B., Zhang S., Zhao X., Zhang W., Hao X. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol. 2004;25:1609–1614. [PubMed] [Google Scholar]
  49. Sun T., Zhao N., Zhao X.L., Gu Q., Zhang S.W., Che N., Wang X. H., Du J., Liu Y.X., Sun B.C. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51:545–556. doi: 10.1002/hep.23311. [DOI] [PubMed] [Google Scholar]
  50. van der Schaft D.W., Seftor R.E., Seftor E.A., Hess A.R., Gruman L.M., Kirschmann D.A., Yokoyama Y., Griffioen A.W., Hendrix M.J. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst. 2004;96:1473–1477. doi: 10.1093/jnci/djh267. [DOI] [PubMed] [Google Scholar]
  51. Vermeulen L., Todaro M., de Sousa Mello F., Sprick M.R., Kemper K., Perez Alea M., Richel D.J., Stassi G., Medema J.P. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A. 2008;105:13427–13432. doi: 10.1073/pnas.0805706105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yang M.H., Hsu D.S., Wang H.W., Wang H.J., Lan H.Y., Yang W. H., Huang C.H., Kao S.Y., Tzeng C.H., Tai S.K., et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol. 2010;12:982–992. doi: 10.1038/ncb2099. [DOI] [PubMed] [Google Scholar]
  53. Yao X.H., Ping Y.F., Chen J.H., Xu C.P., Chen D.L., Zhang R., Wang J.M., Bian X.W. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a Gprotein coupled formylpeptide receptor FPR. J Pathol. 2008;215:369–376. doi: 10.1002/path.2356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Yi L., Zhou Z.H., Ping Y.F., Chen J.H., Yao X.H., Feng H., Lu J.Y., Wang J.M., Bian X.W. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Mod Pathol. 2007;20:1061–1068. doi: 10.1038/modpathol.3800942. [DOI] [PubMed] [Google Scholar]
  55. Yu S.C., Bian X.W. Enrichment of cancer stem cells based on heterogeneity of invasiveness. Stem Cell Rev. 2009;5:66–71. doi: 10.1007/s12015-008-9047-8. [DOI] [PubMed] [Google Scholar]
  56. Yu S.C., Ping Y.F., Yi L., Zhou Z.H., Chen J.H., Yao X.H., Gao L., Wang J.M., Bian X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008;265:124–134. doi: 10.1016/j.canlet.2008.02.010. [DOI] [PubMed] [Google Scholar]
  57. Yue W.Y., Chen Z.P. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem. 2005;53:997–1002. doi: 10.1369/jhc.4A6521.2005. [DOI] [PubMed] [Google Scholar]
  58. Zhang S., Guo H., Zhang D., Zhang W., Zhao X., Ren Z., Sun B. Microcirculation patterns in different stages of melanoma growth. Oncol Rep. 2006;15:15–20. [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES